1 Haem arginate is a new haem compound, recently introduced for the treatment of acute hepatic porphyrias. Porphyrias are characterized biochemically by decreased formation ofhaem due to defects in certain enzyme activities involved in the haem biosynthesis. 2 Haem is essential for cell respiration and oxidative biotransformation. Hepatic drug metabolism, haem biosynthesis and catabolism were investigated after repeated intravenous administration of haem arginate in connection with toxicity studies. 3 The daily doses ofhaem for rats were 4, 12 and 40mg kg-and for dogs 3 and 9mg kg-' for 30 days and for 28 days, respectively. 4 Hepatic microsomes were used in the assay of the following drug metabolizing enzymes: cytochrome P-450 and b5, aminopyrine N-demethylase, ethoxyresorufin O-deethylase and UDPglucuronyl transferase. The assay of NADPH-cytochrome C-reductase and the enzymes reflecting synthesis and metabolism ofhaem in the liver (6-aminolaevulinic acid synthase, 6-aminolaevulinic acid dehydratase, uroporphyrinogen I-synthase, uroporphyrinogen decarboxylase, haem synthase, haem oxygenase and biliverdin reductase) were performed from 20,000g supernatants.
5The lowest dose administered to rats and dogs did not cause any significant changes compared to controls in the parameters measured. 6 The highest doses significantly increased the activities of haem oxygenase and uroporphyrinogen Isynthase but decreased concentrations or activities of other enzymes, e.g. cytochrome P-450 and ethoxyresorufin O-deethylase. 7 The results show that it is important to avoid overdosage of haem when restoration of mixed function oxygenase activity is needed.